Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Big data and artificial intelligence (AI) methodologies for computer-aided drug design (CADD)
Jai Woo Lee, Miguel A. Maria‐Solano, Thi Ngoc Lan Vu, et al.
Biochemical Society Transactions (2022) Vol. 50, Iss. 1, pp. 241-252
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Polo-like Kinase 1 Inhibitors in Human Cancer Therapy: Development and Therapeutic Potential
Jifa Zhang, Lele Zhang, Jiaxing Wang, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 15, pp. 10133-10160
Closed Access | Times Cited: 56
Machine Learning in Antibacterial Drug Design
Marko Jukić, Urban Bren
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 37
Artificial intelligence in accelerating vaccine development - current and future perspectives
Rahul Kaushik, Ravi Kant, Myron Christodoulides
Frontiers in Bacteriology (2023) Vol. 2
Open Access | Times Cited: 22
A New Anticancer Semisynthetic Theobromine Derivative Targeting EGFR Protein: CADDD Study
Ibrahim H. Eissa, Reda G. Yousef, Hazem Elkady, et al.
Life (2023) Vol. 13, Iss. 1, pp. 191-191
Open Access | Times Cited: 15
Big data and artificial intelligence in cancer research
Xifeng Wu, Wenyuan Li, Huakang Tu
Trends in cancer (2023) Vol. 10, Iss. 2, pp. 147-160
Closed Access | Times Cited: 14
Industry 4.0 technologies adoption for digital transition in drug discovery and development: A review
Amit Anthwal, Akshat Uniyal, Jitender Gairolla, et al.
Journal of Industrial Information Integration (2024) Vol. 38, pp. 100562-100562
Closed Access | Times Cited: 5
Targeted Affinity Purification and Mechanism of Action of Angiotensin-Converting Enzyme (ACE) Inhibitory Peptides from Sea Cucumber Gonads
Yangduo Wang, Shicheng Chen, Wenzheng Shi, et al.
Marine Drugs (2024) Vol. 22, Iss. 2, pp. 90-90
Open Access | Times Cited: 5
Deciphering the Lexicon of Protein Targets: A Review on Multifaceted Drug Discovery in the Era of Artificial Intelligence
Suvendu Nandi, Soumyadeep Bhaduri, Debraj Das, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 4, pp. 1563-1590
Closed Access | Times Cited: 5
Optimization of virtual screening against phosphoinositide 3-kinase delta: Integration of common feature pharmacophore and multicomplex-based molecular docking
Jingyu Zhu, Huiqin Meng, Xintong Li, et al.
Computational Biology and Chemistry (2024) Vol. 109, pp. 108011-108011
Closed Access | Times Cited: 4
Artificial Intelligence and Tools in Pharmaceuticals: An Overview
Prasad Patil, Nripesh Kumar Nrip, Ashok A. Hajare, et al.
Research Journal of Pharmacy and Technology (2023), pp. 2075-2082
Closed Access | Times Cited: 13
Revolution of Artificial Intelligence in Computational Chemistry Breakthroughs
Anjaneyulu Bendi, Sanchita Goswami, Prithu Banik, et al.
Chemistry Africa (2024) Vol. 7, Iss. 6, pp. 3443-3459
Closed Access | Times Cited: 3
Integrating Artificial Intelligence to Biomedical Science: New Applications for Innovative Stem Cell Research and Drug Development
M.-G. Kim, Sunghoi Hong
Technologies (2024) Vol. 12, Iss. 7, pp. 95-95
Open Access | Times Cited: 3
Artificial intelligence and cheminformatics tools: a contribution to the drug development and chemical science
Ifra Saifi, Basharat Ahmad Bhat, Syed Suhail Hamdani, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 12, pp. 6523-6541
Closed Access | Times Cited: 10
Can We Quickly Learn to “Translate” Bioactive Molecules with Transformer Models?
Emma Tysinger, K. Brajesh, Anton V. Sinitskiy
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 6, pp. 1734-1744
Closed Access | Times Cited: 9
Site‐Identification by Ligand Competitive Saturation as a Paradigm of Co‐solvent MD Methods
Asuka A. Orr, Alexander D. MacKerell
(2024), pp. 83-118
Closed Access | Times Cited: 2
Optimizing Lead Compounds: The Role of Artificial Intelligence in Drug Discovery
Sarfaraz K. Niazi, Zamara Mariam, Matthias Magoola
(2024)
Open Access | Times Cited: 2
Scaffold repositioning of spiro-acridine derivatives as fungi chitinase inhibitor by target fishing and in vitro studies
Jéssika de Oliveira Viana, Eden Silva e Souza, Nicolau Sbaraini, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 7
TargIDe: a machine-learning workflow for target identification of molecules with antibiofilm activity against Pseudomonas aeruginosa
João Carneiro, Rita P. Magalhães, Victor M de la Oliva Roque, et al.
Journal of Computer-Aided Molecular Design (2023) Vol. 37, Iss. 5-6, pp. 265-278
Open Access | Times Cited: 6
Insights into the Effects and Mechanism of Andrographolide-Mediated Recovery of Susceptibility of Methicillin-Resistant Staphylococcus aureus to β-Lactam Antibiotics
Qiang Ma, Guilai Wang, Na Li, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 5
Through a computer monitor darkly: artificial intelligence in absorption, distribution, metabolism and excretion science.
Dennis A. Smith, Lucy Melanie Burton, Sophie Amanda Smith
Xenobiotica (2024) Vol. 54, Iss. 7, pp. 359-367
Closed Access | Times Cited: 1
Revolutionizing Healthcare: Harnessing the Power of Artificial Intelligence for Enhanced Diagnostics, Treatment and Drug Discovery
Mahmoud Kandeel
International Journal of Pharmacology (2024) Vol. 20, Iss. 1, pp. 1-10
Closed Access | Times Cited: 1
Visualization, Exploration, and Screening of Chemical Space in Drug Discovery
J. Jesús Naveja, Fernanda I. Saldívar‐González, Diana L. Prado‐Romero, et al.
(2024), pp. 365-393
Closed Access | Times Cited: 1
Artificial intelligence in predicting pathogenic microorganisms’ antimicrobial resistance: challenges, progress, and prospects
Yan Li, Xiaoyan Cui, Xiaoyan Yang, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 1
Applications of Big Data and AI-Driven Technologies in CADD (Computer-Aided Drug Design)
Seongmin Seo, Jai Woo Lee
Methods in molecular biology (2023), pp. 295-305
Closed Access | Times Cited: 4
The Intersection of Artificial Intelligence and Big Data in Drug Discovery: A Review of Current Trends and Future Implications
Bankole Ibrahim Ashiwaju, Ochuko Felix Orikpete, Chinedum Gloria Uzougbo
Matrix Science Pharma (2023) Vol. 7, Iss. 2, pp. 36-42
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top